Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

859
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
859
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

388
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
388
Nature and Nurture01:10

Nature and Nurture

22.9K
Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.9K
Relationship with Other Adult Family Members and Siblings01:29

Relationship with Other Adult Family Members and Siblings

254
Other adult family members and siblings play a crucial role in shaping children’s social and emotional development. While parents or primary caregivers are often the central figures in early attachment and socialization, other adults in a child’s life, such as grandparents, aunts, and uncles, can significantly influence developmental outcomes. These influences depend on each adult’s personality and may help compensate when a primary caregiver is emotionally distant or...
254
Parental Care00:55

Parental Care

13.0K
Many animals exhibit parental care behavior, including feeding, grooming, and protecting young offspring. Parental care is universal in mammals and birds, which often have young that are born relatively helpless. Several species of insects and fish, as well as some amphibians, also care for their young.
13.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

811
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
811

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prostaglandin E2-induced arachidonic acid release and catecholamine secretion from cultured bovine adrenal chromaffin cells.

Biochemical pharmacologyยท1992
Same author

Multiple projection of vagal non-myelinated afferents to the anterior insular cortex in rats.

Neuroscience lettersยท1992
Same author

Wear of denture teeth by use of metal plates. Part 3: Abrasive wear of posterior teeth and wear of opposing metal plates.

The Journal of Nihon University School of Dentistryยท1992
Same author

Two sudden death cases of idiopathic ventricular tachycardia.

The Tokushima journal of experimental medicineยท1992
Same author

A case of concealed WPW syndrome with three different reciprocal tachycardias due to triple AV nodal pathways.

The Tokushima journal of experimental medicineยท1992
Same author

Peptidyl antithrombogenic agents for extracorporeal blood circulation.

The International journal of artificial organsยท1992
Same journal

Risk of Hyperkalemia in Patients with Heart Failure Treated with Spironolactone in Combination with Sacubitril/Valsartan vs. Renin-Angiotensin System Inhibitors.

Clinical pharmacology and therapeuticsยท2026
Same journal

Composite Endpoints in Contemporary Cardiovascular Trials: Trends in Phase 3 Trials and Key Issues in Regulatory Review.

Clinical pharmacology and therapeuticsยท2026
Same journal

Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data.

Clinical pharmacology and therapeuticsยท2026
Same journal

Reply to: "The Future of Clinical Pharmacology: The Right Medicine at the Right Dose for Each Patient".

Clinical pharmacology and therapeuticsยท2026
Same journal

Ruxolitinib Pharmacokinetics and Exposure-Toxicity Relationship in Hematologic Malignancies and Immune-Mediated Diseases: A Prospective Observational Study.

Clinical pharmacology and therapeuticsยท2026
Same journal

Repurposing Registries: Completeness of Real-World Data for Regulatory and HTA Purposes in Three Cancer-Focused Registries.

Clinical pharmacology and therapeuticsยท2026
See all related articles

Related Experiment Video

Updated: Apr 10, 2026

Four Temporary Waterslide Designs Adapted to Different Slope Conditions to Encourage Child Socialization in Playgrounds
06:00

Four Temporary Waterslide Designs Adapted to Different Slope Conditions to Encourage Child Socialization in Playgrounds

Published on: December 9, 2022

2.6K

Children: Are We Doing Enough?

S Ito1

  • 1Division of Clinical Pharmacology and Toxicology, Department of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

Clinical Pharmacology and Therapeutics
|June 16, 2015
PubMed
Summary
This summary is machine-generated.

Pediatric medicine use is frequently off-label due to missing data. Sustained regulatory and methodological advancements are crucial for improving child medication safety and efficacy.

More Related Videos

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

28.1K
Physical Activity Measurement in Children Accepting Table Tennis Training
06:51

Physical Activity Measurement in Children Accepting Table Tennis Training

Published on: July 27, 2022

2.6K

Related Experiment Videos

Last Updated: Apr 10, 2026

Four Temporary Waterslide Designs Adapted to Different Slope Conditions to Encourage Child Socialization in Playgrounds
06:00

Four Temporary Waterslide Designs Adapted to Different Slope Conditions to Encourage Child Socialization in Playgrounds

Published on: December 9, 2022

2.6K
Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

28.1K
Physical Activity Measurement in Children Accepting Table Tennis Training
06:51

Physical Activity Measurement in Children Accepting Table Tennis Training

Published on: July 27, 2022

2.6K

Area of Science:

  • Pediatric pharmacology
  • Regulatory science
  • Clinical trial methodology

Background:

  • Many medications used in children are prescribed off-label or without robust evidence, stemming from a historical lack of pediatric-specific research and regulatory considerations.
  • This information gap poses significant risks to pediatric patient safety and treatment effectiveness.

Discussion:

  • Over the past twenty years, substantial progress has been made in developing regulatory frameworks and methodologies to address the unique needs of pediatric drug development.
  • These advancements aim to increase the availability of evidence-based treatments for children.

Key Insights:

  • Despite progress, the use of medicines in children often remains off-label or off-evidence due to persistent information deficits.
  • Regulatory and methodological improvements are evident but require continued commitment.

Outlook:

  • Sustained, collaborative efforts between researchers, regulators, and healthcare providers are essential to ensure a comprehensive evidence base for pediatric pharmacotherapy.
  • Future work should focus on closing remaining knowledge gaps and promoting the consistent application of evidence-based practices in pediatric medicine.